Forging a New Path for Pharma in Value-based Healthcare
Pharma’s role in healthcare is changing amid the rise in more-targeted treatments and a shift in emphasis to preventative medical interventions. Gérard Klop of Vintura…
Pharma’s role in healthcare is changing amid the rise in more-targeted treatments and a shift in emphasis to preventative medical interventions. Gérard Klop of Vintura…
With our growing dependence on social media over the past decade, Digital Opinion Leaders–or “DOLs” for short–are becoming an increasingly important stakeholder group for Pharma…
On May 17th, 500+ of pharma’s clinical innovation will come together for the home of clinical collaboration, Reuters Events: Pharma Clinical 2022, to set new…
Novel and Advanced Therapies have made great strides over the past decade but that means that manufacturing process consistency, GMP standards and so on must…
Biopharma start-ups need to identify the best data-management processes and systems – but to do so means they need to avoid the mistakes made by…
The European Commission recently unveiled two long-awaited proposals on digital services and digital markets. While we don’t yet know how—or when—these measures will be enacted,…
2021 was a significant year for the advancement of healthcare, perhaps even more so than when the pandemic first hit the entire global population in…
Trust between clinical research organisations (CROs) and sponsors – a person or organisation that establishes and supports healthcare plans – is essential for running successful clinical…
For pharmaceutical companies, negative publicity is always a risk. The success of research, trials and the rollout of a product is dependent on the trust…
The Covid-19 pandemic caused massive disruptions amongst clinicians, patients and communities. Labs, hospitals and clinical sites shut overnight, and research teams worked endlessly for months…